BioM Venture Capital

Founded -

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$12M
Portfolio companies 4
Lead investments 1
Exits 3
Key employees Soon
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
Summary

The main office of represented VC is situated in the Martinsried. The venture was found in Europe in Germany.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the BioM Venture Capital, startups are often financed by ATHOS Service. The meaningful sponsors for the fund in investment in the same round are Unternehmertum Venture Capital Partners, TransConnect, Global Life Science Ventures. In the next rounds fund is usually obtained by Unternehmertum Venture Capital Partners, Global Life Science Ventures, Gilde IT Fund.

Among the most successful fund investment fields, there are Health Care, Manufacturing. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight apceth Biopharma, Pieris AG.

The important activity for fund was in 2002. The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this BioM Venture Capital performs on 38 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2019. Deals in the range of 5 - 10 millions dollars are the general things for fund.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

apceth Biopharma

Biotechnology
Genetics
Manufacturing
$5M04 Feb 2013 Munich, Bavaria, Germany

U3 Pharma

Biotechnology
Health Care
$16M06 Oct 2003 Germany, Bavaria, Germany

Pieris AG

Biotechnology
Health Care
Medical
Pharmaceutical
$14M31 Oct 2002 Germany, Bavaria, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioM Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: